Rod Cells & AMD: The Night-Vision Breakthrough That Changes Early Detection
Topic: Eye Health | Macular Degeneration | Scientific Research | Vision Loss Prevention
Rod Cells — The Night-Vision Cells — Are the First to Die in AMD
"Rod dysfunction is one of the earliest signs of many retinal diseases, including AMD and retinitis pigmentosa. Being able to directly monitor the rods' response to light gives us a powerful tool for disease detection and tracking treatment responses earlier and with greater sensitivity than any conventional diagnostic instrument." — Prof. Ramkumar Sabesan, University of Washington School of Medicine
For the first time in history, an international research team led by Nanyang Technological University, Singapore (NTU Singapore), in collaboration with the University of Washington, the Singapore Eye Research Institute, and Duke-NUS Medical School, has recorded a tiny mechanical "twitch" in living human eyes — at the exact moment a rod photoreceptor detects light.
What Are Rod Photoreceptors — And Why Do They Matter for AMD?
Rod photoreceptors are the cells in your retina responsible for vision in low-light conditions — your night vision. They make up approximately 95% of all photoreceptors in the human retina. In age-related macular degeneration (AMD), these "night-vision cells" are often the first to deteriorate, causing difficulty seeing in dim environments long before central vision loss becomes obvious.
Using an advanced imaging method called optoretinography (ORG) — which detects incredibly small movements in eye cells without any dyes or labels — the research team discovered that rod photoreceptors undergo a rapid contraction of up to 200 nanometres within roughly 10 milliseconds of light reaching the retina. This motion is triggered when rhodopsin, the eye's light-sensitive molecule, is activated — representing one of the earliest steps in converting light into visual signals the brain can process.
Lead investigator Dr. Tong Ling, Nanyang Assistant Professor at NTU, explained: "The 'twitch' of the eye's night-vision cells is akin to the ignition spark of vision. We have long known that these cells produce electrical signals when they absorb light, but no one had, until now, ever reported the accompanying mechanical contraction of these cells inside the living eyes of humans or rodents."
The Critical AMD Connection
Rod photoreceptors are the cells most vulnerable to AMD damage. When the macula begins to degenerate, the rod cells in and around the central retina start losing their ability to respond to light — producing the characteristic night blindness and difficulty adapting to darkness that AMD patients experience years before significant central vision loss occurs.
This new technology offers, for the first time, a non-invasive way to detect rod dysfunction at the cellular level — potentially catching AMD damage before it becomes irreversible. As Professor Jost Jonas, Chairman of Ophthalmology at Heidelberg University, stated: "This holds the promise of a more detailed, and potentially earlier, diagnosis of retinal diseases, in particular disorders primarily affecting the photoreceptors."
The findings were published in the peer-reviewed journal Light: Science & Applications and first presented at the Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting — one of the world's leading ophthalmology congresses.